Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Shares Outstanding (Weighted Average): 2022-2025

Historic Shares Outstanding (Weighted Average) for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $70.9 million.

  • Phathom Pharmaceuticals' Shares Outstanding (Weighted Average) rose 19.05% to $70.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.9 million, marking a year-over-year increase of 19.05%. This contributed to the annual value of $68.4 million for FY2024, which is 19.43% up from last year.
  • According to the latest figures from Q3 2025, Phathom Pharmaceuticals' Shares Outstanding (Weighted Average) is $70.9 million, which was up 1.62% from $69.8 million recorded in Q2 2025.
  • In the past 5 years, Phathom Pharmaceuticals' Shares Outstanding (Weighted Average) ranged from a high of $70.9 million in Q3 2025 and a low of $31.7 million during Q1 2022.
  • Over the past 3 years, Phathom Pharmaceuticals' median Shares Outstanding (Weighted Average) value was $58.5 million (recorded in 2024), while the average stood at $59.5 million.
  • Data for Phathom Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 45.00% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Phathom Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $41.6 million in 2022, then spiked by 37.56% to $57.3 million in 2023, then rose by 19.43% to $68.4 million in 2024, then grew by 19.05% to $70.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $70.9 million for Q3 2025, versus $69.8 million for Q2 2025 and $69.6 million for Q1 2025.